CGN:LYX
$0.02
-
0.00%
Cognetivity Neurosciences Ltd - Ordinary SharesNews & Events
Last updated: May 9, 2025, 5:33 AM ET
Canadian Investment Regulatory Organization Trading Halt - CGN
Canada Newswire JUN 6, 2024 8:27 AM EDTCanadian Investment Regulatory Organization Trading Halt - CGN Canada NewsWire ...READ ARTICLECognICA(TM) Shown to Save Tens of Millions of Dollars in Healthcare Costs Annually and Improve Patient Outcomes in the UK National Health Service
Newsfile OCT 24, 2023 9:00 AM EDTLatest Peer-Reviewed Study Published in Frontiers in Public Health Highlights Cost-Efficiency and...READ ARTICLECognetivity Neurosciences and UC Health Partner to Improve Early Detection of Cognitive Impairment in USA
Newsfile OCT 11, 2023 9:00 AM EDTCollaboration With Highly Rated Healthcare Provider Opens US Healthcare Market for Brain Health f...READ ARTICLECognetivity Neurosciences Announces Commercial Agreement with Mediclinic to Provide Cognitive Assessment to Over 50s
Newsfile OCT 3, 2023 9:24 AM EDTProgram Designed to Identify Age-Related Brain Health Issues at an Early Stage, Allowing Effectiv...READ ARTICLECognetivity Neurosciences Partners with No Fear Counselling to Pioneer Brain Health Assessment Through Groundbreaking AI Technology
Newsfile SEP 21, 2023 9:15 AM EDTNew Approach to Measuring Impact of Counselling to Deliver Next Generation Care to Mental Health ...READ ARTICLECognetivity Neurosciences' AI Powered CognICA Platform Wins Major Industry Award
Newsfile SEP 13, 2023 9:00 AM EDTCognICA Chosen as Winner of Best AI Product in Healthcare Award at CogX Festival Vancouver, Brit...READ ARTICLECognetivity Neurosciences' AI Powered CognICA Platform Shortlisted for Major Industry Award
Newsfile SEP 5, 2023 8:45 AM EDTCognICA Shortlisted for Most Innovative AI Product in Healthcare Award at CogX Festival Vancouve...READ ARTICLECognetivity Neurosciences Announces Publication of Peer-Reviewed Article Showing Effectiveness of its AI Powered CognICA Technology in Detecting Early-Stage Alzheimer's Disease
Newsfile AUG 30, 2023 8:45 AM EDTCognetivity's Landmark ADePT Study, Funded by the UK Innovation Agency and Published in Leading N...READ ARTICLECognetivity Neurosciences Announces Successful Registration With Health Canada for Clinical use of CognICA(TM) AI-Powered Brain Health Technology in Canada
Newsfile AUG 2, 2023 8:48 AM EDTApproval opens up a new major market for CognICA, providing a solution to the urgent requirement ...READ ARTICLENew Disease Modifying Drug for Alzheimer's Disease Fully Approved by FDA, Highlighting the Crucial Role for Cognetivity in Early Detection and Monitoring
Newsfile JUL 7, 2023 9:00 AM EDTVital breakthrough for Alzheimer's patients worldwide with Eisai's Leqembi FDA approval; Cognetiv...READ ARTICLE